Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.04%
#2 Ocean Protocol Ocean Protocol +21.09%
#3 KUB Coin KUB Coin +16.96%
#4 Audiera Audiera +14.74%
#5 Geodnet Geodnet +13.74%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.18%
#7 Arowana Arowana +7.88%
#8 DexNet DexNet +7.78%
#9 Cysic Cysic +7.51%
#10 Ontology Gas Ontology Gas +6.91%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Rapid Dose Therapeutics Corp. Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

DOSE
Clasificación en acciones #32492
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life... Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
Precio por acción
$0.07339369
Última sincronización: 2026-08-17
Capitalización bursátil
$9.92M
Cambio (1 día)
-4.76%
Cambio (1 año)
-48.06%
País
CA
Comercio Rapid Dose Therapeutics Corp. (DOSE)

Categoría

Healthcare
Ingresos de Rapid Dose Therapeutics Corp. (DOSE)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Rapid Dose Therapeutics Corp., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Rapid Dose Therapeutics Corp. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR